20 Results

People

  1. Hassoun
    Hassoun
  2. Nimer
    Nimer
  3. Comenzo
    Comenzo
  4. Klimek
    Klimek
  5. Kewalramani
    Kewalramani
  6. Reich
    Reich
  7. Dhodapkar
    Dhodapkar
  8. Fleisher
    Fleisher
  9. Landau
    Landau
  10. Cohen
    Cohen

Groups

  1. Adult Leukemia (20)
  2. Center for Hematologic Malignancies (20)
  3. Department of Medicine (20)
  4. Hematologic Malignancies, Division of (20)
  5. Myeloma (20)
  6. Bone Marrow Transplant (10)
  7. Survivorship Research (10)
  8. Hematologic Malignancies Research (5)
  9. Biostatistics Service (4)
  10. Epidemiology and Biostatistics (4)
  1. "Adult Leukemia"
  2. "Center for Hematologic Malignancies"
  3. "Myeloma"
  4. "Hani Hassoun"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (8)
Groups
  1. Adult Leukemia (20)
  2. Center for Hematologic Malignancies (20)
  3. Department of Medicine (20)
  4. Hematologic Malignancies, Division of (20)
  5. Myeloma (20)
  6. Bone Marrow Transplant (10)

More Groups

People
  1. Hani Hassoun (20)
  2. Stephen Nimer (13)
  3. Raymond Comenzo (12)
  4. Virginia Klimek (12)
  5. Tarun Kewalramani (11)
  6. Lilian Reich (10)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2018 (1)
  5. 2017 (2)
  6. 2013 (1)

More Years

Publications
  1. Blood (13)
  2. Bone Marrow Transplantation (2)
  3. Blood Advances (1)
  4. British Journal of Haematology (1)
  5. Leukemia (1)
  6. Leukemia and Lymphoma (1)

More Publications

Publishers
  1. American Society of Hematology (14)
  2. Nature Publishing Group (3)
  3. John Wiley & Sons (1)
  4. Massachusetts Medical Society (1)
  5. Taylor & Francis Group (1)

Results (20)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lenalidomide-associated B-cell ALL: Clinical and pathologic correlates and sensitivity to lenalidomide withdrawal
    Journal Article

    Geyer, M. B.; Shaffer, B. C.; Bhatnagar, B.; Mims, A. S.; Klein, V.; Dilip, D.; Glass, J. L.; Lozanski, G.; Hassoun, H.; Landau, H.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • GPRC5D-targeted CAR T cells for myeloma
    Journal Article

    Mailankody, S.; Devlin, S. M.; Landa, J.; Nath, K.; Diamonte, C.; Carstens, E. J.; Russo, D.; Auclair, R.; Fitzgerald, L.; Cadzin, B.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Phase I first-in-class trial of MCARH109, a G protein coupled receptor class C group 5 member D (GPRC5D) targeted CAR T cell therapy in patients with relapsed or refractory multiple myeloma
    Meeting Abstract

    Mailankody, S.; Diamonte, C.; Fitzgerald, L.; Kane, P.; Wang, X.; Sikder, D. S.; Senechal, B.; Bermudez, V. P.; Frias, D.; Morgan, J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial
    Meeting Abstract

    Mailankody, S.; Ghosh, A.; Staehr, M.; Purdon, T. J.; Roshal, M.; Halton, E.; Diamonte, C.; Pineda, J.; Anant, P.; Bernal, Y.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Clinical and pathological features of B-cell acute lymphoblastic leukemia following maintenance treatment with lenalidomide for multiple myeloma
    Meeting Abstract

    Geyer, M. B.; Shaffer, B. C.; Landau, H.; Hassoun, H.; Famulare, C.; Roshal, M.; Dogan, A.; Arcila, M. E.; Park, J. H.
    Blood (2017)

    Fulltext@MSK | Save
  • Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantation
    Journal Article

    Shah, G. L.; Landau, H.; Londono, D.; Devlin, S. M.; Kosuri, S.; Lesokhin, A. M.; Lendvai, N.; Hassoun, H.; Chung, D. J.; Koehne, G.; more...
    Leukemia and Lymphoma (2017)

    Fulltext@MSK | Save
  • Pilot study to evaluate the prevalence of actionable oncogenic mutations in patients with relapsed refractory multiple myeloma
    Meeting Abstract

    Lesokhin, A.; Gonen, M.; Redling, K.; Lendvai, N.; Hassoun, H.; Landau, H.; Chung, D. J.; Koehne, G.; Patel, M.; Brennan, K. W.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • CD32B expression reflects phenotypic and functional heterogeneity in multiple myeloma (MM)
    Meeting Abstract

    Zhou, P.; Boruchov, A. M.; Hoffman, J. E.; Mo, Q. X.; Olshen, A.; Glasner, E.; Bonvini, E.; Koenig, S.; Drieghe, E.; Fleisher, M.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Sequential administration of bortezomib, liposomal doxorubicin and dexamethasone (BDD) followed by thalidomide and dexamethasone (TD) results in rapid control of untreated high-risk multiple myeloma (MM) and improves depth of response
    Meeting Abstract

    Landau, H.; Hassoun, H.; Cohen, A.; Hoover, E.; Kewalramani, T.; Boruchov, A.; Klimek, V.; Reich, L.; Riedel, E.; Pandit-Taskar, N.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease
    Journal Article

    Hassoun, H.; Flombaum, C.; D'Agati, V. D.; Rafferty, B. T.; Cohen, A.; Klimek, V. M.; Boruchov, A.; Kewalramani, T.; Reich, L.; Nimer, S. D.; more...
    Bone Marrow Transplantation (2008)

    Fulltext@MSK | Save